The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study
- 31 October 2005
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 182 (2) , 301-305
- https://doi.org/10.1016/j.atherosclerosis.2005.02.006
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery diseaseInternational Journal of Molecular Medicine, 2004
- RAGE: A Novel Target for Drug Intervention in Diabetic Vascular DiseasePharmaceutical Research, 2004
- The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic PlaquesCirculation, 2003
- The Functional −374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic PatientsDiabetes, 2003
- Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patientsJournal of Diabetes and its Complications, 2002
- RAGE and arthritis: the G82S polymorphism amplifies the inflammatory responseGenes & Immunity, 2002
- Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDMJournal of Diabetes and its Complications, 2001
- Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes.Diabetes Care, 1999
- The framingham offspring study. Design and preliminary dataPreventive Medicine, 1975
- Epidemiological Approaches to Heart Disease: The Framingham StudyAmerican Journal of Public Health and the Nations Health, 1951